REATA PHARMACEUTICALS INC shareholders Q2 2023

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.

REATA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atika Capital Management LLC 22,000$2,243,1200.22%
Nan Fung Group Holdings Ltd 3,300$336,4680.22%
FRED ALGER MANAGEMENT, LLC 407,170$41,515,0530.21%
Virtus ETF Advisers LLC 3,362$342,7900.20%
WOODSTOCK CORP 14,285$1,456,4990.17%
Point72 Asset Management, L.P. 568,151$57,928,6760.17%
Blueshift Asset Management, LLC 4,007$408,5540.16%
Polar Asset Management Partners Inc. 83,400$8,503,4640.15%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 311,358$31,746,0620.15%
Blackstone Inc. 340,793$34,747,2540.15%
Caption Management, LLC 81,400$8,299,5440.15%
SECURITY NATIONAL BANK OF SO DAK 1,975$201,3710.14%
Tekla Capital Management LLC 34,250$3,492,1300.14%
DRIEHAUS CAPITAL MANAGEMENT LLC 94,945$9,680,5920.12%
Caption Management, LLC 67,000$6,831,3200.12%
NinePointTwo Capital LLC 2,868$2920.11%
Schonfeld Strategic Advisors LLC 114,520$11,676,4590.10%
CAPITAL COUNSEL LLC/NY 17,000$1,733,3200.10%
Ikarian Capital, LLC 5,472$557,9250.09%
Headlands Technologies LLC 2,602$265,3000.08%
External links

This page lists REATA PHARMACEUTICALS INC's shareholders in Q2 2023. To view REATA PHARMACEUTICALS INC's shareholder history, click here.